Neximmune Inc

NASDAQ:NEXI   10:08:27 AM EDT
2.79
0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Neximmune Inc Stock, NASDAQ:NEXI

9119 Gaither Road, Gaithersburg, Maryland 20877
United States of America
Phone: +1.301.825.9810
Number of Employees: 6

Description

NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.